Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma
, , , and
Apr 30, 2007
About this article
Published Online: Apr 30, 2007
Page range: 23 - 32
DOI: https://doi.org/10.2478/v10019-007-0004-y
Keywords
This content is open access.
Novaković, Barbara
Kotnik, Vladimir
Šetina, Tanja
Vovk, Marjeta
Novaković, Srdjan